Alamo Group Inc.

11 days ago · zacks.com

Investors need to pay close attention to ALG stock based on the movements in the options market lately.

3 months ago · globenewswire.com

SOUTH SAN FRANCISCO, Calif., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that dosing has been initiated in the Phase 1 study of ALG-170675, an investigational next-generation antisense oligonucleotide (ASO) being evaluated for functional cure in the treatment of chronic hepatitis B virus (HBV) infection. The study is being conducted in China by Xiamen Amoytop Biotech Co., Ltd. (“Amoytop”), who maintain rights in Greater China.

3 months ago · seekingalpha.com

Alamo Group Inc. (ALG) Q2 2026 Earnings Call Transcript

3 months ago · marketbeat.com

Alamo Group NYSE: ALG reported second-quarter 2026 net sales of $415.7 million, up 7.6% from a year earlier, as acquisitions and modest organic growth supported results. Organic net sales rose 1.3%, while adjusted diluted earnings per share increased 7.2% to $2.82.

3 months ago · zacks.com

Alamo Group (ALG) came out with quarterly earnings of $2.82 per share, beating the Zacks Consensus Estimate of $2.74 per share. This compares to earnings of $2.57 per share a year ago.

3 months ago · prnewswire.com

SEGUIN, Texas, Aug. 3, 2026 /PRNewswire/ -- Alamo Group Inc. (NYSE: ALG) today reported results for the second quarter of 2026. Highlights:   Net sales were $450.7 million, up 7.6% compared to the second quarter of 2025 Net income was $30.9 million and adjusted net income was $34.2 million Fully diluted EPS was $2.55 per share, nearly flat compared to $2.57 per share in the second quarter of 2025 Adjusted fully diluted EPS was $2.82 per share, an increase of 7.2% compared to $2.63 per share in the second quarter of 2025 Adjusted EBITDA of $63.9 million was 14.2% of net sales, up 8.7% compared to the second quarter of 2025 Net sales in the Industrial Equipment Division were $271.6 million, up 12.8% compared to the second quarter of 2025 Net sales in the Vegetation Management Division were $179.1 million, up 0.4% compared to the second quarter of 2025 The Company renewed its credit facility in May 2026 with improved terms and preserved $602.5 million of committed capacity, including a $400.0 million revolver and $202.5 million term loan facility On June 30, 2026, cash was $195.0 million and total debt was $262.7 million  Returned $19.0 million to stockholders in the first six months of 2026, including $10.8 million of share repurchases and $8.2 million of dividends Robert Hureau, Alamo Group's President and Chief Executive Officer, commented, "Our second quarter results reflect continued execution across the business, highlighted by strong sales growth in our Industrial Equipment Division, improved adjusted earnings, and solid adjusted EBITDA performance.

3 months ago · zacks.com

Investors looking for stocks in the Manufacturing - Farm Equipment sector might want to consider either Alamo Group (ALG) or Deere (DE). But which of these two companies is the best option for those looking for undervalued stocks?

3 months ago · zacks.com

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

3 months ago · zacks.com

The mean of analysts' price targets for Alamo Group (ALG) points to a 28.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

4 months ago · zacks.com

Investors looking for stocks in the Manufacturing - Farm Equipment sector might want to consider either Alamo Group (ALG) or Deere (DE). But which of these two companies is the best option for those looking for undervalued stocks?